Evidence Synthesis Manager, HTA
Japan - Tokyo - Akasakaremotemanager
Posted today · via Workday
About this role
Job purpose: Reporting to the Evidence Strategy & Operations Lead, this role operates across therapeutic areas to deliver payer‑focused evidence generation, drive HEOR activities for priority assets. The role has a strong HTA focus and will drive HTA submission projects, prioritising evidence packages and dossier development to meet local HTA and reimbursement requirements; coordinate evidence generation, modelling and stakeholder engagement; and provide HTA‑specific scientific and strategic input to secure favourable access outcomes.…
Read the full description on 825 Glaxo Wellcome Manufacturing Pte's site →
What we'd score you on
reqspace match rubricFive dimensions, recruiter-grade. Upload your resume and we'll generate a written explanation of where you fit and where the gaps are.
1
Skills match
For this role: teams
2
Level fit
This role is manager-level. We check your trajectory against it.
3
Domain experience
Your work in the role's domain matters more than your years total. We weight recent and direct experience.
4
Recency
A skill you used last quarter weighs more than one from five years ago. We grade on recency, not lifetime.
5
Location fit
This role is remote-eligible — we factor in your stated location and time-zone overlap.
Score yourself on this role.
Free · no card · written explanation included
Skills in this role
Pulled from the job description. These are the keywords we'll weight when scoring your fit.
teams
More at 825 Glaxo Wellcome Manufacturing Pte
- View →Beca Mejora Continua en Investigación ClínicaGSK Tres Cantos, Madrid
- View →Career Conversion Programme (AnT) - Production EngineerSingapore - Tuas
- View →Finance Director TurkeyIstanbul River Plaza
- View →Site Transformation Lead(m/f/d - temp position for 12 months)Heidelberg - Office
- View →Senior/ Manufacturing EngineerSingapore - Jurong
- View →Stage en alternance : Communication Digitale & Support au Changement, Belgique – 2026Belgium-Wavre
